MAPK8 and glioblastoma: The results of the CCK8 and TUNEL assays showed that the enhanced cytotoxicity and apoptosis of TMZ induced by IN-1 were reversed upon combined treatment with SP600125, indicating that HPGDS promotes drug resistance of GBM by inhibiting the activation of the JNK pathway (Figure 9B,D–F).